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Scalp allotransplantation monozygotic twins who had no need for immunosuppressive therapy, in which two flap operations were performed based on the superficial temporal artery. The transplant was successful and hair growth from the flap was observed after long-term monitoring [1] . The other case was that of a 72-year-old woman with stage IIIC recurrent cutaneous malignant melanoma of the parietal scalp. The patient was treated with a wide excision, including part of the scalp, the face, the neck, and both ears. The resulting defect was reconstructed using a composite tissue allotransplantation, including both ears and the scalp from a young man who had been declared brain dead [2] .
Patients who undergo scalp allotransplantations need continuous immunosuppressive therapy that can pose life-threatening complications. Unlike other organ transplants such as kidney or liver, the functional or cosmetic improvement due to a scalp transplant does not extend a patient's life. Thus, scalp allotransplantation raises ethical questions [3] . Furthermore, patients may have ethical objections or experience mental distress due to the fact that the scalp was removed from a brain-dead person [4] . Therefore, it is important to objectively measure and evaluate the level of risks and benefits of composite tissue allotransplantation before actual application.
Recent studies have reported gaps in the knowledge regarding risk acceptance and expectations for composite tissue allotransplantation between experts and non-experts in a number of countries.
In South Korea, similar studies have been conducted to evaluate risk acceptance and expectations for allotransplantation of the face, hands, feet, and larynx [5] [6] [7] . However, no such survey study has been performed on scalp allotransplantation within South Korea.
METHODS

Samples
The questionnaire study incorporated four subpopulations with- 
General public group
The author conducted the survey to 100 individuals who came with their family members to the outpatient department of our institute between March 2013 and April 2015. The participants ranged in age from 23 to 75 years (mean age, 44.8±13.3 years).
Kidney transplantation recipients group
The kidney transplantation recipients at our institution were given the same questionnaire survey (n=50). The patients in this group were between 32-year-old and 64-year-old (mean age, 48.9
±8.2 years).
Post-scalp reconstruction patients group
The third group consisted of patients who had undergone reconstruction of scalp defect from tumor excision or trauma between December 2007 and November 2014. Of the 50 patients completing survey, free flap operation had been performed in 2 patients, with the 48 remaining patients having received skin grafts. The scalp defect sizes ranged from 4 to 170 cm 2 , and the causes of tissue defect was trauma in 24 cases and tumor resection in 26 cases.
The patients were between 29 and 80 years of age (mean age, 60.6 ±10.7 years).
Doctor group
The survey was administered to a group of 100 resident doctors working at our institute, with ages ranging from 26 to 36 years (mean age, 31.0±2.8 years).
Survey method
Barker et al., provided the potential scenarios for allotransplantation of the face, hands, feet, kidney, and larynx, and developed the Louisville instrument for transplantation (LIFT), which is a survey tool used to objectively evaluate the degree of risk acceptable in relation to the potential benefits through composite tissue allotransplantation [5] .
Kim et al. [8] translated the English version of the LIFT into the Korean language with the help of an expert translator, and then investigated the reliability and validity of the LIFT questionnaire, as well as risk acceptance and expectations of allotransplantation of the face, hands, feet, and larynx. In the present study, the same method was used for studying risk acceptance and expectations for scalp allotransplantation.
Evaluators were plastic surgery residents, who explained the technical, ethical, and social aspects of scalp allotransplantation to participants before the questionnaire was provided. The translated LIFT questionnaire was completed by the participants. The evaluators were allowed to assist in explaining medical concepts to the lay persons to allow for revision of answers.
To help with understanding the potential need for scalp allotransplantation, participants were provided with photographs of various scalp defects and non-allotransplantation reconstruction outcomes, to help them understand that traditional scalp defect reconstruction results in an unnatural appearance. The adverse reactions caused by taking immunosuppressive agents after surgery were also explained to the participants. The participants also understood that, if tissue rejection occurred after scalp allotransplantation, reoperation with autologous tissue without hair would be necessary.
Survey contents
Risk acceptance of scalp allotransplantation
Risk acceptance is a concept representing the degree of risk that can be accepted in return for particular benefits. The present study investigated two aspects of risk acceptance: adverse reactions to immunosuppression and tissue rejection risks.
Risk acceptance of the side effects of immunosuppression
Patients were advised that adverse reactions of immunosuppression can range from relatively minor symptoms such as nausea, vomiting, diarrhea, constipation, weight gain, dizziness, and headache to serious complications such as infection, tumor, hypertension, diabetes, and toxicity to peripheral organs. They were also notified that in case of severe tissue rejection, the graft would have to be removed. They were instructed to express their intention to receive scalp allotransplantation by responding "yes" or "no" after considering the adverse reaction risk from immunosuppression. Assuming that the remaining lifespan would be 10 years, the length of lifespan they would be willing to give up due to adverse reactions to immunosuppression was also investigated ( Fig. 1) . 
Risk acceptance of tissue rejection
When the risk of rejection within 1 year of scalp allotransplantation was assumed to be 50%, they were instructed to express their intentions to receive transplantation by "yes" or "no" responses, and were also requested to indicate the maximum degree of risk for tissue rejection acceptable for them to still undergo scalp allotransplantation (a higher number meant greater intention to accept risk) (Fig. 2) .
Expectations of scalp allotransplantation
Expectations of quality of life
For assessment of quality of life expectations, participants were requested to score the quality of life they assumed they would have because of the unpleasant appearance, or 'ugliness', of hairless scalp, and the change in quality of life after scalp allotransplantation. They were asked to answer using Arabic numerals from 0 to 10, where the worst condition was represented by a '0' and the best condition was represented by a '10'. In order to avoid confusion on what constitutes ugliness of a hairless scalp, participants were also given pre/postoperative photographs of the patient who had scalp allotransplantation to the parietal area for stage IIIC recurrent cutaneous malignant melanoma (Fig. 3) .
Functional improvement after transplantation and importance of function and appearance
When it was assumed that the remaining lifespan would be decreased by 1/3 due to adverse reactions of the immunosuppression treatment, each group indicated the minimum degree of functional improvement for which they could accept the treatment. They were asked to select a number from 0 to 100, by which a higher number meant a higher improvement.
In addition, participants were asked to indicate the importance of function and appearance of the scalp to be transplanted with a number from 0 to 10, in which a higher number meant more important (Fig. 4) .
Statistical analysis
Collected data were recorded and summarized using Excel (Microsoft Office Excel 2010, Microsoft Corp, Redmond, WA, USA).
Statistical analysis was performed using the statistical package SPSS (SPSS ver. 15.0, SPSS Inc., Chicago, IL, USA). One-way analysis of variance was conducted to compare the differences between groups, post hoc multiple comparisons were performed to identify areas of clear differences, and a chi-square test was used for analysis of dichotomous risk acceptance survey questions. All the significance levels were set to less than 5%.
RESULTS
Examination of risk acceptance of scalp allotransplantation
Risk acceptance of the side effects of immunosuppression
Considering adverse reactions to immunosuppression, 86% of the general public and 92% of the group who underwent kidney transplantation responded positively to scalp allotransplantation, which was higher than the proportion in the group that had undergone reconstruction for defects on the scalp (60%) and the doctor group (68%). With the assumption that the expected lifespan was only 10 years, the maximum percentages of lifespan that participants would give up after scalp allotransplantation surgery was 31.4% for the general public group, 41.6% for the kidney transplantation group, 24.4% for scalp reconstruction group, and 20.7%
for the doctor group.
One-way analysis of variance found significant differences among the four groups (p<0.001). However, the post hoc multiple comparison found no clear difference between the scalp reconstruction group and the doctor group (p=0.611) (Fig. 5 ).
Risk acceptance of tissue rejection
Assuming a 50% risk of rejection in the first year after scalp allotransplantation, 69% of the general public group and 74% of the group with kidney transplantation answered 'yes' to having scalp allotransplantation, which were higher than those of the scalp reconstruction group (40%) and the doctor group (55%) (p<0.001).
Furthermore, the maximum acceptable risk of tissue rejection was 44.7% for the general public group and 48.6% for the group with kidney transplantation, which was significantly different from the other two groups (p<0.001). There was no significant difference between the general public group (44.7%) and kidney transplantation group (48.6%) (p=0.561) nor between the scalp re- construction group (30.2%) and the doctor group (31.9%) (p=0.941) (Fig. 5) .
Examination of group expectations of scalp allotransplantation
Quality of life
Quality of life after hairless reconstruction was given the following scores: 3.1 for the general public group, 3.4 for the group with kidney transplantation, 2.3 for the scalp reconstruction group, and 2.2 for the doctor group (p<0.001). Quality of life after scalp allotransplantation were given scores of 8.3, 8.4, 7.4, and 7.5 for the general public group, the group that underwent kidney transplantation, the group that had undergone reconstruction for defects on the scalp, and the doctor group, respectively. While the quality of life scores differed across all four groups (all p<0.05), the most significant difference was found in comparisons between the doctors and the general public group (p=0.003) (Fig. 6 ).
Expected function after transplantation
Assuming immunosuppressive drugs would reduce the remaining life span by 1/3, reduction of the remaining lifespan was acceptable to 74% of the general public, 75% of the kidney transplantation group, 73% of the scalp reconstruction group, and 68% of the doctor group, as long as the transplanted scalp was fully functional (p=0.117) (Fig. 6 ).
Importance of function and appearance
The importance of improvement in appearance of the scalp after scalp allotransplantation was rated 7.7, 7.9, 7.3, and 6.6 by the general public group, the group with kidney transplantation, the scalp reconstruction group, and the doctor group, respectively (p<0.001). The importance of normal function of the scalp in comparison to appearance was rated 7.0, 7.0, 6.9, and 5.7 by the general public group, the group with kidney transplantation, the scalp reconstruction group, and the doctor group, respectively (p<0.001).
DISCUSSION
Although scalp allotransplantation presents minimal surgical difficulty, the procedure is as complex as any organ transplantation due to the issues related to immunity. First, serological screening tests and ABO blood typing need to be performed to assess immune compatibility between donors and recipients. In addition, donor-recipient compatibility must be evaluated for age, No episode of acute rejection has been reported for the two cases of scalp allotransplantation, but recipients must remain on lifelong immunosuppressive therapy and need to be carefully monitored for occurrence of chronic graft versus host disease.
Compared to solid organ transplantation, scalp allotransplantation is challenged by a different set of problems. First, scalp transplant does not extend life, which raises ethical questions for patients whose life may be shortened due to immunosuppressive management [9] . Second, it is difficult to find a donor due to the cultural issues surrounding the procurement of scalp. A third difficulty is the selection of a recipient with good compliance for a successful scalp allotransplantation. The recipient will need to undergo screening for clear understanding of the risks and benefits through psychiatric evaluations, such as for schizophrenia, and an IQ test [10] .
A "frame of reference" can be defined as a set of ideas, beliefs, and/or views that is used for predicting a conclusion in psychological terms and for making decision. Barker et al. suggested that since such frame of references should be observed for various groups involved in transplantations (laypersons, potential patients, physicians, etc.) because those frames modify the perception of the risks and benefits of transplantation [11] . In our study, the differences in risk acceptance and expectations for scalp transplantation across the groups most likely reflect the differences in frame of reference across the four groups.
In our study, the kidney transplantation group gave acceptable scores on the survey for risk acceptance and expectations, which seemed to indicate that they already understood immunosuppressive therapy through direct experience. Such personal experiences seems to have raised the consensus threshold value for risk acceptance. It is important to note, however, that only kidney transplantation survivors were included as group members, and the results may reflect a selection bias for positive outlook.
In contrast, the general public group gave relatively higher risk acceptance and expectation scores, which seemed to be mainly related to a lack of practical knowledge on the subject matter.
Since most of the general public has little or no in depth knowledge about scalp allotransplantation, the survey evaluators had to provide additional explanations regarding scalp allotransplantation and immunosuppression during the survey.
Participants who had received scalp reconstruction responded differently from the transplant patients and the general public. The present study found results, which echo findings from other international studies and that from the allotransplantation conducted within South Korea [5] [6] [7] 12] . Despite differences in transplantation type and study populations, the fact that study results were similar indicates that the most influential factor could be "expectations" of the general public group with the lack of knowledge regarding subject matter. Therefore, it is important for patients to fully understand the various difficulties of scalp allotransplantation before surgery to allow each individual to evaluate whether or not the post-transplant outcomes are acceptable.
For scalp transplantation to be a viable practice in modern medicine, physicians should not solely focus on the adverse reactions of immunosuppression and low expectations, but also increase the effort on minimizing such risks and on satisfying the cosmetic or functional requirements of patients. In addition, the public should be informed against the unrealistic expectations of allotransplantation based on incorrect portrayal from popular media.
The present study investigated differencesin the risk acceptance and expectations of scalp allotransplantation in specific sub-groups of the South Korean population and has found findings similar to those of other populations.
Scalp allotransplantation is feasible operation for large scalp defect patients. However, physicians must understand the differences in risk acceptance and expectations across various groups of the lay public and recognize the advantages and disadvantages of scalp allotransplantation.
